Clinical Study of Adbelimumab in the Adjuvant Treatment of Esophageal Squamous Cell Carcinoma.
Clinical trial NCT07266480 · RECRUITING
Trial details
- NCT number
- NCT07266480
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2027-09-01
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.